Please login to the form below

Not currently logged in
Email:
Password:

Duchesnay

This page shows the latest Duchesnay news and features for those working in and with pharma, biotech and healthcare.

FDA slams Kardashian West's Instagram drug promotion

FDA slams Kardashian West's Instagram drug promotion

s Office of Prescription Drug Promotion to write to the drug's manufacturer Duchesnay. ... Since then, Duchesnay has acknowledged that its communications, including in social media, “need to be in accordance with all applicable rules and regulations”.

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    Duchesnay, the Canadian women’s health company, has acquired from Shionogi the rights to market Osphena, another oral treatment for dyspareunia, in North America.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics